SS
Satya Srini Vasan
About Satya Srini Vasan
Data last updated:
Satya Srini Vasan is a Director at Ankur Healthcare Private Limited (since 2010), Director at Ankur Andrology & Mens Health Private Limited (since 2012) and Director at Essement Biosciences Private Limited (since 2022), and holds 1 more current directorship. The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹13.27 Cr; the largest is Ankur Healthcare Private Limited at ₹13.15 Cr (FY 2025). Earlier, Satya Srini Vasan was a Director at Centre Of Human Reproduction And Biosciences Private Limited (2015–2020) and Director at Mothersense Technologies Private Limited (2020–2022) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Feb 2010 | 2010 | ₹13.15 Cr (FY 2025) | Active | |
| Director | 07 Mar 2012 | 2012 | ₹12 Lakh (FY 2024) | Active | |
| Director | 04 Nov 2022 | 2022 | Active | ||
| Director | 09 May 2011 | 2011 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Feb 2015 | 2004 | ₹3.29 Cr (FY 2025) | Active | |
| Director | 07 Dec 2020 | 2020 | ₹10.26 Cr (FY 2024) | Active | |
| Director | 06 Sep 2011 | 2011 | ₹49,876 (FY 2016) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Satya Srini Vasan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bangalore Venkatesh Shobha | 10987163 | Ankur Healthcare Private Limited , Ankur Andrology & Mens Health Private Limited | Director |
| Nishita Vasan | 05116611 | Ankur Andrology & Mens Health Private Limited | Director |
| Ritvik Vasan | 05116627 | Ankur Andrology & Mens Health Private Limited | Director |
| Sheeba Lobo | 09783073 | Essement Biosciences Private Limited | Director |
| Noel John Kappala | 02487342 | Ankur Healthcare (Ongole) Private Limited | Director |
| Radha Radhakrishnan | 02283552 | Ankur Healthcare (Ongole) Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satya Srini Vasan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satya Srini Vasan
Satya Srini Vasan currently holds 4 directorships: Ankur Healthcare Private Limited (Director, since 15 Feb 2010, revenue ₹13.15 Cr (FY 2025)); Ankur Andrology & Mens Health Private Limited (Director, since 07 Mar 2012, revenue ₹12 Lakh (FY 2024)); Essement Biosciences Private Limited (Director, since 04 Nov 2022); Ankur Healthcare (Ongole) Private Limited (Director, since 09 May 2011).
Satya Srini Vasan was first appointed on 15 Feb 2010 as Director at Ankur Healthcare Private Limited. The most recent appointment on record is 04 Nov 2022 at Essement Biosciences Private Limited.
The 2 current companies of Satya Srini Vasan that report revenue have a combined latest revenue of ₹13.27 Cr: Ankur Healthcare Private Limited ₹13.15 Cr (FY 2025); Ankur Andrology & Mens Health Private Limited ₹12 Lakh (FY 2024).
Satya Srini Vasan held 3 earlier board appointments: Centre Of Human Reproduction And Biosciences Private Limited (Director, 13 Feb 2015 to 28 Sep 2020); Mothersense Technologies Private Limited (Director, 07 Dec 2020 to 31 Jan 2022); Ankur Healthcare (Raichur) Private Limited (Director, from 06 Sep 2011).
The current boards of Satya Srini Vasan's companies include Bangalore Venkatesh Shobha (Ankur Healthcare Private Limited), Nishita Vasan (Ankur Andrology & Mens Health Private Limited), Ritvik Vasan (Ankur Andrology & Mens Health Private Limited), Sheeba Lobo (Essement Biosciences Private Limited), Noel John Kappala (Ankur Healthcare (Ongole) Private Limited), Radha Radhakrishnan (Ankur Healthcare (Ongole) Private Limited).